Navigation Links
Nature study demonstrates that bacterial clotting depends on clustering
Date:11/2/2008

Bacteria can directly cause human blood and plasma to clota process that was previously thought to have been lost during the course of vertebrate evolution, according to new research at the University of Chicago, National Institute of Allergy and Infectious Diseases, and Institut Pasteur in Paris. Their findings will be published online Nov. 2 in Nature Chemical Biology.

The discovery will improve scientists' understanding of coagulation during bacterial infections and may lead to new clinical methods for treating serious medical conditions such as sepsis and anthrax.

It has long been known that blood often coagulates during sepsis or bacterial infections, but this has generally been regarded as a host's immune and inflammatory response. It also has been known that bacteria can activate factors that precede coagulation, but it had not previously been known that bacteria can pass the coagulation threshold and cause blood clots to form. Once they form, the clots can grow and propagate. Although this may help prevent the dissemination of the bacteria through the host, it often leads to serious vascular damage due to blocked and injured blood vessels.

The key to clot formation is the location of the bacteria, rather than the total number of bacteria or their level of concentration. In other words, for those bacteria that can activate coagulation factors, coagulation occurs only when a cluster of bacteria forms.

"Our research demonstrates that coagulation can be controlled by changing the spatial distribution, or clustering, of bacteria," said study co-author Christian Kastrup, Post-Doctoral Assistant at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. "Therefore, considering the location of bacterial cells, instead of just their presence or absence and their total numbers, could significantly change our understanding of coagulation."

Kastrup, who worked on this research as a graduate
'/>"/>

Contact: Greg Borzo
gregborzo@uchicago.edu
773-702-8366
University of Chicago
Source:Eurekalert

Page: 1 2

Related biology news :

1. Genes and environment grant funds close look at nature-nurture overlap in common diseases
2. Nature leads the way for the next generation of paints, cosmetics and holograms
3. Costa Rica, US announce historic debt-for-nature swap
4. New ETH Zurich article published in scientific journal Nature
5. Frog study takes leaf out of natures book
6. Scientists enhance Mother Natures carbon handling mechanism
7. Entrust Digital Signatures Help Secure More Than 18 Million U.S. ePassports
8. Iridescence workshop promotes natures nanotechnology
9. In nature -- and maybe the corner office -- scientists find that generalists can thrive
10. Genes selective signature aids detection of natural selection in microbial evolution
11. K-State contributions to red flour beetle genome sequencing featured in March 27 issue of Nature

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...O, Calif., Nov. 9 Genencor, a divi... Energy Award" from the American Institute of Chem...amily of enzymes for cellulosic ethanol. Yesterday...e, presented the award to Landon Steele, who is Ma...#174; Product Manager, and Aaron Kelley, who is Se...
(Date:11/9/2009)... culprit responsible for the rapid, mysterious dea...s been found by collaborating scientists at Rutger...itution (WHOI). This same chemical may hold unexp...covered a previously unknown lipid, or fatty compo...g Emiliania huxleyi , a phytoplankton that plays ...
(Date:11/9/2009)..., NOVEMBER 9, 2009 A nutritionist whose research...to the federal Women, Infants and Children (WIC) f...Higgins Award for outstanding achievement in the f...son, Ph.D., MNS, , a professor in the Department o...alifornia, Los Angeles School of Public Health, wi...
Breaking Biology News(10 mins):Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 1SEI Defined Benefit Client Recognized With Leading Plan Design Award 5454 2DuraHeart 26amp 3B 238482 3B Third Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio th 59434 1DuraHeart 26amp 3B 238482 3B Third Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio th 59434 2DuraHeart 26amp 3B 238482 3B Third Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio th 59434 3Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 1Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 2Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 3
...he primary targets of HIV-1 infection in the human... study published in the February 2007 issue of the...ndings are likely to guide development of new stra...he majority of HIV-1 infected individuals worldwid...xual contact," explain study authors Dr. Florian H...
...n his Jan. 23 State of the Union address, Presiden...on,s dependency on foreign oil by requiring the pr... and alternative fuels by 2017, roughly five times... gallons by 2012. , Among the most promising alter.... Currently, the main biofuel used in the United S...
...n his Jan. 23 State of the Union address, Presiden...on,s dependency on foreign oil by requiring the pr... and alternative fuels by 2017, roughly five times... gallons by 2012. , Among the most promising alter.... Currently, the main biofuel used in the United S...
Other Biology News:Researchers discover new details about HIV-1 entry and infection 2Custom-made cancer cell attacks 2Custom-made cancer cell attacks 3Cellulosic ethanol: Fuel of the future? 2Cellulosic ethanol: Fuel of the future? 3
(Date:11/6/2009)...wire-FirstCall/ - Microbix Biosystems Inc. (the "C...Form 52-109F1 Certification of Annual Filings of W...es Long, the Chief Financial Officer (the "Officer...tion with the annual audited financial statements ...ompany initially filed the annual financial statem...
(Date:11/6/2009)... Helix BioPharma Corp. (...ced that John Docherty, president and chief operat...s 6th annual Investor Summit on November 10, 2009 ... Mr. Docherty will provide an overview of the Comp... and Topical Interferon Alpha-2b. The slide show ...
(Date:11/6/2009)...vember 6 EUCODIS Bioscience, a com...arketing enzymes for the,chemical industry announc...ment with Bio Sidus, the leading biopharmaceutical...t gives EUCODIS Bioscience exclusive access - for ...proprietary collection of,psychrophilic bacteria s...
(Date:11/6/2009)...Nov. 6 Calbiotech, Inc. announced ...novative Research (SBIR) Phase I contract by the U...der terms of the agreement, Calbiotech will develo...is of Dengue virus. ,, Dengue virus is a mos...at to military forces deployed to tropical areas o...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...d., March 16 Micromet, Inc. (Nasdaq: MITI ), a ...etary antibodies for the treatment of cancer, infl...the publication of six abstracts for poster presen... place from April 20-24, 2009, in Denver, Colorado... , , , Lutterbuese, R. et al. (2009). H...
...ch 16 PAREXEL experts will address the benefits o... 110th Annual Meeting of the American Society for ... be held at the Gaylord National Resort in Nationa...ocus of PAREXEL,s presence at the ASCPT meeting wi...nd best practice approaches for identifying and se...
...ng expenses decreased by 33% in 2008; Forecast cut...n 2009 , , CTI expects to complete pixantrone ND...ell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC...ial results for the fourth quarter and year ended ... Met primary endpoint in the Phase III study ...
Other Biology Technology:Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 2Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 3Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 4Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research 5PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting 2PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting 3PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting 4Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 2Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 3Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 4Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 5Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 6Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 7Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results 8
cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio
Goat Anti-DOCK 2 (E-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-PFK-2 car (P-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Ampicillin Monoclonal Antibody, Unconjugated, Clone 164-12-2 from Abcam
Biology Products: